Is Hologic's Share Price Undervalued?

Hologic's share price has declined by 5.9% over the last three years and 1% over the last five years, despite a 7.5% return over the past year. The company's valuation score is 4/6, indicating that it is undervalued based on its discounted cash flow (DCF) analysis. The DCF model estimates an intrinsic value of $105.82 per share, which is a 29.1% discount to the current share price of $74.98.